Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1957 1
1958 4
1961 5
1962 4
1963 3
1964 11
1965 5
1966 9
1967 10
1968 15
1969 18
1970 12
1971 15
1972 19
1973 21
1974 13
1975 25
1976 20
1977 27
1978 27
1979 24
1980 33
1981 45
1982 51
1983 55
1984 66
1985 60
1986 52
1987 67
1988 72
1989 73
1990 65
1991 59
1992 74
1993 74
1994 72
1995 78
1996 70
1997 76
1998 98
1999 70
2000 107
2001 99
2002 118
2003 166
2004 145
2005 155
2006 148
2007 153
2008 156
2009 180
2010 154
2011 190
2012 193
2013 196
2014 235
2015 297
2016 239
2017 172
2018 165
2019 156
2020 206
2021 224
2022 202
2023 131
2024 116
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,368 results

Results by year

Filters applied: . Clear all
Page 1
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Yasuda S, et al. Among authors: ogawa h. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. N Engl J Med. 2019. PMID: 31475793 Clinical Trial.
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. Among authors: ogawa h. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01).
Yamaguchi J, Yokoyama Y, Fujii T, Yamada S, Takami H, Kawashima H, Ohno E, Ishikawa T, Maeda O, Ogawa H, Kodera Y, Nagino M, Ebata T. Yamaguchi J, et al. Among authors: ogawa h. Ann Surg. 2022 Jun 1;275(6):1043-1049. doi: 10.1097/SLA.0000000000005430. Epub 2022 Mar 3. Ann Surg. 2022. PMID: 35258510 Clinical Trial.
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators. Tsujita K, et al. Among authors: ogawa h. J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065. J Am Coll Cardiol. 2015. PMID: 26227186 Free article. Clinical Trial.
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Kohagura K, Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kohagura K, et al. Among authors: ogawa h. Hypertens Res. 2023 Jun;46(6):1417-1422. doi: 10.1038/s41440-023-01198-x. Epub 2023 Feb 7. Hypertens Res. 2023. PMID: 36750608 Clinical Trial.
Staphylococcus aureus δ-toxin present on skin promotes the development of food allergy in a murine model.
Yamada H, Kaitani A, Izawa K, Ando T, Kamei A, Uchida S, Maehara A, Kojima M, Yamamoto R, Wang H, Nagamine M, Maeda K, Uchida K, Nakano N, Ohtsuka Y, Ogawa H, Okumura K, Shimizu T, Kitaura J. Yamada H, et al. Among authors: ogawa h. Front Immunol. 2023 May 19;14:1173069. doi: 10.3389/fimmu.2023.1173069. eCollection 2023. Front Immunol. 2023. PMID: 37275864 Free PMC article.
Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease.
Ishii M, Kaikita K, Yasuda S, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Nishihara E, Nakamura S, Matsui K, Ogawa H, Tsujita K; AFIRE Investigators. Ishii M, et al. Among authors: ogawa h. Open Heart. 2023 May;10(1):e002292. doi: 10.1136/openhrt-2023-002292. Open Heart. 2023. PMID: 37173099 Free PMC article. Clinical Trial.
Nonlinear feedforward enabling quantum computation.
Sakaguchi A, Konno S, Hanamura F, Asavanant W, Takase K, Ogawa H, Marek P, Filip R, Yoshikawa JI, Huntington E, Yonezawa H, Furusawa A. Sakaguchi A, et al. Among authors: ogawa h. Nat Commun. 2023 Jul 12;14(1):3817. doi: 10.1038/s41467-023-39195-w. Nat Commun. 2023. PMID: 37438372 Free PMC article.
Reply.
Tanaka Y, Tane S, Hokka D, Ogawa H, Maniwa Y. Tanaka Y, et al. Among authors: ogawa h. Ann Thorac Surg. 2017 Jul;104(1):370. doi: 10.1016/j.athoracsur.2016.12.004. Ann Thorac Surg. 2017. PMID: 28633232 No abstract available.
5,368 results